UROMAX 15 MG
OXYBUTYNIN CHLORIDE : 15 MG · DIN 02273586 · PURDUE PHARMA
Health Canada status: CANCELLED POST MARKET
What is UROMAX?
UROMAX 15 MG contains OXYBUTYNIN CHLORIDE : 15 MG. It is listed in the Health Canada Drug Product Database under DIN 02273586, held by PURDUE PHARMA, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02273586 |
|---|---|
| Brand name | UROMAX |
| Generic / active ingredient | OXYBUTYNIN CHLORIDE : 15 MG |
| Manufacturer | PURDUE PHARMA |
| Strength | 15 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G04BD04 OXYBUTYNIN |
| AHFS class | 84:80.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2013 |
| Original market date | 2006-04-12 00:00:00 |
Is OXYBUTYNIN in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Discontinued — reported by SANIS HEALTH INC, last seen 04 Jun 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code G04BD04 OXYBUTYNIN. 5 of 35 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-OXYBUTYNIN | 5 MG | TABLET | APOTEX INC | MARKETED | DIN 02163543 |
| PMS-OXYBUTYNIN | 2.5 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02240549 |
| PMS-OXYBUTYNIN | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02240550 |
| PMS-OXYBUTYNIN | 5 MG / 5 ML | SYRUP | PHARMASCIENCE INC | MARKETED | DIN 02223376 |
| TEVA-OXYBUTYNIN | 5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02230394 |
| ALBERT OXYBUTYNIN | 5 MG | TABLET | AVENTIS PHARMA INC | CANCELLED POST MARKET | DIN 02220067 |
| APO-OXYBUTYNIN | 1 MG | SYRUP | APOTEX INC | DORMANT | DIN 02231089 |
| AVA-OXYBUTYNIN | 5 MG | TABLET | AVANSTRA INC | CANCELLED POST MARKET | DIN 02363917 |
| DITROPAN SYRUP 1MG/ML | 1 MG | SYRUP | JANSSEN INC | CANCELLED POST MARKET | DIN 01924753 |
| DITROPAN TABLETS 5MG | 5 MG | TABLET | JANSSEN INC | CANCELLED POST MARKET | DIN 01924761 |
Who else supplies OXYBUTYNIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OXYBUTYNIN appears in 39 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.